Purdue University Recognizes OmniVis for its Most Fundable Company Designation
OmniVis, a Purdue University-affiliated biotechnology company focused on the speed, accuracy, and economics of pathogen detection, was named to the fifth annual Most Fundable Companies list from Pepperdine University’s Graziadio Business School last fall.
In a recent press release distributed by Purdue, the university recognized OmniVis for its accomplishments. OmniVis received the Gold designation from Graziadio, the second highest recognition possible.
More than 4,000 early-stage US companies across all 50 states participated in the Most Fundable Companies initiative, which is a free resource to assist startups in securing capital to accelerate meaningful innovation across industries and communities. The companies on the fifth annual list are located across the US and come from a variety of industries including healthcare technology, energy, horticulture, and consumer products.
“The Most Fundable Companies process involved six months of due diligence on OmniVis, providing even further confidence behind everything we are doing at the company,” said Katherine Clayton, OmniVis CEO and Perdue alumnus. “By winning the Most Fundable Companies, we were able to extend our network by meeting great entrepreneurs and investors as well as those excited about entrepreneurship. We can’t wait for what comes next.”
Read the full press release on the Purdue University website. Read more about the 2022 Most Fundable Companies here.